entity

FTLD-TDP

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about FTLD-TDP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections
0Hypotheses
1Analyses
1Outgoing
5Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (3)

Knowledge base pages for this entity

FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation

experiment · 1855 words

FTLD-TDP Subtypes and Mechanisms

mechanism · 1780 words

Biomarkers to Distinguish FTLD-tau from FTLD-TDP

biomarker · 1330 words

Outgoing (1)

TargetRelationTypeStr
Neuronal Inclusionsassociated_withphenotype0.90

Incoming (5)

SourceRelationTypeStr
TARDBPcomponent_ofprotein0.95
ANXA11associated_withprotein0.95
TDP-43associated_withprotein0.95
20145419are the most common known cause ofpaper0.90
TREM2 R47H variantincreases_riskgene0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the optimal timing windows for TREM2 agonism vs antagonism across disea

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate highlighted that TREM2 therapeutic targeting remains contested across

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Related Research

Hypotheses and analyses mentioning FTLD-TDP in their description or question text

No additional research found